175 related articles for article (PubMed ID: 35313756)
1. Prognostic significance of mean platelet volume in patients with lung cancer: a meta-analysis.
Kharel S; Shrestha S; Shakya P; Rawat R; Shilpakar R
J Int Med Res; 2022 Mar; 50(3):3000605221084874. PubMed ID: 35313756
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer.
Inagaki N; Kibata K; Tamaki T; Shimizu T; Nomura S
Lung Cancer; 2014 Jan; 83(1):97-101. PubMed ID: 24189108
[TBL] [Abstract][Full Text] [Related]
4. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy.
Sakin A; Secmeler S; Arici S; Geredeli C; Yasar N; Demir C; Aksaray F; Cihan S
Sci Rep; 2019 Mar; 9(1):3959. PubMed ID: 30850724
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis.
Yuan Y; Zhong H; Ye L; Li Q; Fang S; Gu W; Qian Y
BMC Pulm Med; 2020 Apr; 20(1):96. PubMed ID: 32312252
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis.
Chen X; Li J; Zhang X; Liu Y; Wu J; Li Y; Cui X; Jiang X
BMJ Open; 2020 Oct; 10(10):e037614. PubMed ID: 33109647
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of preoperative mean platelet volume in resected non-small-cell lung cancer.
Kumagai S; Tokuno J; Ueda Y; Marumo S; Shoji T; Nishimura T; Fukui M; Huang CL
Mol Clin Oncol; 2015 Jan; 3(1):197-201. PubMed ID: 25469294
[TBL] [Abstract][Full Text] [Related]
10. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis.
Wang Z; Wang Y; Zhang X; Zhang T
Clin Chim Acta; 2018 Nov; 486():303-310. PubMed ID: 30138620
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
13. Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor.
Watanabe K; Yasumoto A; Amano Y; Kage H; Goto Y; Yatomi Y; Takai D; Nagase T
PLoS One; 2018; 13(9):e0203625. PubMed ID: 30192878
[TBL] [Abstract][Full Text] [Related]
14. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.
Tuncel T; Ozgun A; Emirzeoglu L; Celik S; Bilgi O; Karagoz B
Asian Pac J Cancer Prev; 2014; 15(15):6421-3. PubMed ID: 25124636
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic roles of the mean platelet volume in malignant tumors: a systematic review and meta-analysis.
Pyo JS; Sohn JH; Kang G
Platelets; 2016 Dec; 27(8):722-728. PubMed ID: 27162007
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
[TBL] [Abstract][Full Text] [Related]
18. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Platelet (PLT) and Platelet to Mean Platelet Volume (PLT/MPV) Ratio During Apatinib Second-Line or Late-Line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients.
Su R; Zhu J; Wu S; Luo H; He Y
Technol Cancer Res Treat; 2022; 21():15330338211072974. PubMed ID: 35072577
[No Abstract] [Full Text] [Related]
20. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
